|Bid||246.50 x 800|
|Ask||249.72 x 1000|
|Day's range||246.30 - 249.85|
|52-week range||198.64 - 258.45|
|Beta (5Y monthly)||0.56|
|PE ratio (TTM)||21.12|
|Earnings date||31 Oct 2022 - 04 Nov 2022|
|Forward dividend & yield||7.76 (3.12%)|
|Ex-dividend date||17 Aug 2022|
|1y target est||253.17|
Amgen Inc. ( NASDAQ:AMGN ) is about to trade ex-dividend in the next 3 days. Typically, the ex-dividend date is one...
Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
Earnings updates from Amgen (AMGN) and its ChemoCentryx (CCXI) acquisition are a few key highlights from the biotech sector during the past week.